Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

Summary

This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.

Timeline

Start

2020-02-18

Primary completion

2020-03-16

Completion

2020-03-16

Publications

• Squillace S, Salvemini D. Nitroxidative stress in pain and opioid-induced adverse effects: therapeutic opportunities. Pain. 2022 Feb 1;163(2):205-213. doi: 10.1097/j.pain.0000000000002347. No abstract available.

Drugs

Indications